|
| MR Improvement (N = 16) | No MR Improvement (N = 20) | P-value |
| Age (years) | 68.8 ± 9 | 70.7 ± 10 | 0.56 |
| Diabetes | 62.5% (10) | 60.0% (12) | 0.88 |
| BMI | 30.4 ± 6 | 30.4 ± 7 | 1.00 |
| Hypertension | 87.5% (14) | 85.0% (17) | 0.83 |
| ESRD | 0% | 5.0% (1) | 0.36 |
| LVEF < 55% | 32.1% (5) | 25.0% (5) | 0.68 |
| Current smoking | 12.5% (2) | 15.0% (3) | 0.83 |
| MR worse than mild | 31.2% (5) | 5.0% (1) | 0.04 |
| MAC | 31.2% (5) | 55.0% (11) | 0.20 |
| Bicuspid | 18.8% (3) | 25.0% (5) | 0.65 |
| AVA | 0.73 ± 0.1 | 0.75 ± 0.2 | 0.67 |
| AV mean gradient | 48.8 ± 15 | 40.8 ± 10 | 0.07 |
| AoA systolic diameter | 23.6 ± 2 | 23.1 ± 1 | 0.14 |
| AoA diastolic diameter | 23.6 ± 2 | 23.3 ± 2 | 0.07 |
| AVR prosthetic size | 22.6 ± 1 | 23.1 ± 1 | 0.23 |
| LAE | 68.8% (11) | 65.0% (13) | 0.60 |
| Atrial fibrillation | 18.8% (3) | 10.0% (2) | 0.40 |
| Maze procedure | 12.5% (2) | 10.0% (2) | 0.81 |
| CABG | 43.8% (7) | 30.0% (6) | 0.39 |